Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Safety and Clinical Impact of Bedside Microenvironmental Monitoring in Infected Walled-Off Pancreatic Necrosis During Standard Percutaneous Drainage

NCT07131917 is registered in ClinicalTrials.gov with Martin Harazim as lead sponsor.

NCT NCT07131917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07131917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Safety and Clinical Impact of Bedside Microenvironmental Monitoring in Infected Walled-Off Pancreatic Necrosis During Standard Percutaneous Drainage
Lead sponsor
Martin Harazim
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
June 15, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, walled off pancreatic necrosis